The evaluation of the efficacy and toxicity of targeted treatment in non-small cell lung cancer patients – single centre experience
Journal Title: OncoReview - Year 2017, Vol 7, Issue 2
Abstract
Introduction: Tyrosine kinase inhibitors (TKI) are the standard of treatment in patients with advanced non-small cell lung cancer (NSCLC) with EGFR (endothelial growth factor receptor) gene activating mutation. Objective: The evaluation of the efficacy and toxicity of TKI drugs in NSCLC patients treated in single centre. Material and methods: NSCLC patients treated with TKI (gefitinib, erlotynib, afatinib) between 2012– 2016 were retrospectively analysed. We evaluated: overall response rate (ORR) which is the sum of complete responses (CR) and partial remissions (PR), progression free survival (PFS), overall survival (OS) and adverse events (AE) according to CTCAE (Common Terminology Criteria for Adverse Events) scale. Results: The study group were 16 patients ORR was 50% (CR: 1, PR: 7). Median PFS and OS was 8,7 and 22,9 months respectively. Adverse events observed mainly in stage 1 and 2 were related to hyponatraemia, hyperbilirubinemia, skin toxicity and mucositis. There was one death reported due to infectious complications. Conclusion: The efficacy and toxicity of TKI in study group were found to be similar to those described in the literature.
Authors and Affiliations
Joanna Kardas, Agnieszka Buraczewska, Paweł Chrom, Waśko-Grabowska Anna, Beata Młot, Cezary Szczylik
Keywords
Related Articles
- EP ID EP189867
- DOI 10.24292/01.OR.300617.7
- Views 217
- Downloads 0
Application of echocardiography in oncology – practical remarks
The paper presents the contemporary use of echocardiography in diagnosis of primary and metastatic tumors of the heart as well as in assessment of cardiovascular risk related to medical and interventional oncological the...
Wybrane aspekty stosowania inhibitorów kinaz tyrozynowych w terapii chorych na nowotwory podścieliskowe przewodu pokarmowego
Nowotwory podścieliskowe przewodu pokarmowego (GIST, gastrointestinal stromal tumor) są najczęstszymi nowotworami złośliwymi pochodzenia mezenchymalnego przewodu pokarmowego. Najczęściej umiejscawiają się w żołądku i jel...
Zastosowanie filtrów żylnych w profilaktyce przeciwzakrzepowej przed zabiegami onkologicznymi
Jedną z najczęstszych przyczyn powikłań i zgonów pacjentów onkologicznych jest żylna choroba zakrzepowo-zatorowa. Postępowanie lecznicze w tej grupie chorych sprowadza się przede wszystkim do odpowiedniej farmakoterapii....
Childhood Cancer Survivorship Late Cardiotoxicity, and CV Prevention
Ongoing research developments in cardio-oncology